Zobrazeno 1 - 10 of 170 pro vyhledávání: '"Theodore B Moore"'
1
Akademický článek
A review of nutrition and dietary interventions in oncology
Autor: Ashley Gray, Brian N Dang, Theodore B Moore, Roger Clemens, Peter Pressman
Publikováno v: SAGE Open Medicine, Vol 8 (2020)
The complex cellular mechanisms and inter-related pathways of cancer proliferation, evasion, and metastasis remain an emerging field of research. Over the last several decades, nutritional research has prominent role in identifying emerging adjuvant
Externí odkaz: https://doaj.org/article/88ef4b75203e49b5a60d1b63ac2df543
Zobrazit plný text záznamu
2
Akademický článek
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial
Autor: Suzanne Braniecki, Elliott Vichinsky, Mark C. Walters, Shalini Shenoy, Qiuhu Shi, Theodore B. Moore, Julie-An Talano, Susan K. Parsons, Allyson Flower, Anne Panarella, Sandra Fabricatore, Erin Morris, Harshini Mahanti, Jordan Milner, Robert C. McKinstry, Christine N. Duncan, Carmella van de Ven, Mitchell S. Cairo
Publikováno v: Frontiers in Neurology, Vol 15 (2024)
BackgroundDue to the risk of cerebral vascular injury, children and adolescents with high-risk sickle cell disease (SCD) experience neurocognitive decline over time. Haploidentical stem cell transplantation (HISCT) from human leukocyte antigen-matche
Externí odkaz: https://doaj.org/article/1ffd73bb5fe045e7b11a68a31f21a4a3
Zobrazit plný text záznamu
3
Akademický článek
Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
Autor: Ashley N. Gray, Nicole H. Tobin, Theodore B. Moore, Fan Li, Grace M. Aldrovandi
Publikováno v: International Journal of Medical Microbiology, Vol 313, Iss 3, Pp 151580- (2023)
Allogeneic Hematopoietic Cell Transplantation (HCT) offers children with life-threatening diseases a chance at survival. Complications from graft-versus-host disease (GVHD, Stages 0–4) represent a significant cause of morbidity and mortality which
Externí odkaz: https://doaj.org/article/21e131107d7045a98e17000f009021b3
Zobrazit plný text záznamu
4
Akademický článek
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
Autor: Yaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, James W. Verbsky, Erin Morris, Harshini Mahanti, Janet Ayello, Carolyn Keever-Taylor, Bryon Johnson, Rona S. Weinberg, Qiuhu Shi, Theodore B. Moore, Sandra Fabricatore, Brenda Grossman, Carmella van de Ven, Shalini Shenoy, Mitchell S. Cairo
Publikováno v: Frontiers in Immunology, Vol 13 (2022)
IntroductionWe previously reported the initial results of a phase II multicenter transplant trial using haploidentical parental donors for children and aolescents with high-risk sickle cell disease achieving excellent survival with exceptionally low
Externí odkaz: https://doaj.org/article/b0d0c172bee649e4b8a967bf44eea504
Zobrazit plný text záznamu
5
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy
Autor: Jack Pengfei Tang, Cole W. Peters, Crystal Quiros, Xiaoyan Wang, Alexandra M. Klomhaus, Reiko E. Yamada, John M. Timmerman, Theodore B. Moore, Theodore S. Nowicki
Publikováno v: Cancer immunology research, vol 10, iss 12
Cancer Immunol Res
A major complication of chimeric antigen receptor (CAR) T-cell therapy is immune effector cell–associated neurotoxicity syndrome (ICANS), which presents as aphasia, confusion, weakness, somnolence, seizures, and coma. This is similar to the neurolo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0f8f770d6b22bd92fe70d4e1f67a66
https://doi.org/10.1158/2326-6066.cir-22-0418
Zobrazit plný text záznamu
8
Data from Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy
Autor: Theodore S. Nowicki, Theodore B. Moore, John M. Timmerman, Reiko E. Yamada, Alexandra M. Klomhaus, Xiaoyan Wang, Crystal Quiros, Cole W. Peters, Jack Pengfei Tang
A major complication of chimeric antigen receptor (CAR) T-cell therapy is immune effector cell–associated neurotoxicity syndrome (ICANS), which presents as aphasia, confusion, weakness, somnolence, seizures, and coma. This is similar to the neurolo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28435b9d50fb3fc83c5654bc12e969c3
https://doi.org/10.1158/2326-6066.c.6550821.v1
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje